SL
EW icon

Savior LLC’s Edwards Lifesciences EW Stock Holding History

Savior LLC’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-330
Closed -$34K – 375
2021
Q2 		$34K Sell
330
-48
-13% -$4.52K 0.03% 206
2021
Q1 		$32K Hold
378
– – 0.03% 211
2020
Q4 		$34K Hold
378
– – 0.03% 197
2020
Q3 		$30K Hold
378
– – 0.04% 192
2020
Q2 		$26K Buy
378
+48
+15% +$3.41K 0.03% 191
2020
Q1 		$21K Sell
330
-15
-4% -$1.08K 0.02% 195
2019
Q4 		$27K Buy
+345
New +$26.9K 0.04% 247

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Savior LLC's EW Position: Q3 2021 in Review

Savior LLC sold out of Edwards Lifesciences (EW) in Q3 2021, closing a stake of 330 shares — an estimated $34K sold.

Savior LLC first reported a position in EW in Q4 2019 and held it in 7 quarters. The position peaked at $34K in Q2 2021. 1,229 funds tracked by Wall St. Rank hold EW as of Q3 2021.

  • Savior LLC reported no remaining Edwards Lifesciences position as of Q3 2021 after selling out during the quarter.
  • Savior LLC sold 330 Edwards Lifesciences shares in Q3 2021, an estimated $34K.
  • Savior LLC first reported a position in Edwards Lifesciences in Q4 2019 and held it in 7 quarters.
  • Savior LLC's Edwards Lifesciences position peaked at $34K in Q2 2021.
  • 1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2021.

Based on Savior LLC's 13F filing for Q3 2021, filed 5 Oct 2021.